Follow-up
We evaluated the treatment response, survival outcomes, and toxicity
using medical records. Follow-up data available as of April 2020 were
included in the analysis. Hematological and nonhematological toxicity
after IREC therapy were graded according to the National Cancer
Institute Common Terminology Criteria for Adverse Events version 5.0.